Volume 54, Issue 1, Pages (January 2011)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes 
Volume 63, Issue 1, Pages (July 2015)
Volume 67, Issue 1, Pages (July 2017)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Volume 65, Issue 6, Pages (December 2016)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Non-invasive diagnosis of non-alcoholic fatty liver disease
Liver Transplantation in a Patient With Sitosterolemia and Cirrhosis
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity  Samyah Shadid, Michael D Jensen  Clinical Gastroenterology.
Volume 42, Issue 4, Pages (April 2005)
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 137, Issue 3, Pages (September 2009)
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 3, Pages (September 2014)
Volume 54, Issue 5, Pages (May 2011)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Michael Charlton  Clinical Gastroenterology and Hepatology 
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Volume 69, Issue 3, Pages (September 2018)
Volume 50, Issue 4, Pages (April 2009)
Volume 69, Issue 5, Pages (November 2018)
AGA technical review on nonalcoholic fatty liver disease
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Chronic hepatitis B in children and adolescents
Liver transplantation in children
Cholesterol and all-cause mortality in Honolulu
Volume 68, Issue 5, Pages (May 2018)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Volume 50, Issue 1, Pages 4-6 (January 2009)
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Volume 54, Issue 1, Pages 153-159 (January 2011) Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity  Piia Simonen, Anna Kotronen, Maarit Hallikainen, Ksenia Sevastianova, Janne Makkonen, Antti Hakkarainen, Nina Lundbom, Tatu A. Miettinen, Helena Gylling, Hannele Yki-Järvinen  Journal of Hepatology  Volume 54, Issue 1, Pages 153-159 (January 2011) DOI: 10.1016/j.jhep.2010.05.037 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The absolute and relative differences of markers of cholesterol synthesis (desmosterol, lathosterol, cholestenol) and absorption (cholestanol, campesterol, sitosterol) between NAFLD and control subjects. Adjusted for BMI and gender. All differences are statistically significant. Journal of Hepatology 2011 54, 153-159DOI: (10.1016/j.jhep.2010.05.037) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions